Chordoma Cancer: Diagnosis, Outlook and Treatment

Chordoma cancer is a rare tumor that develops from remnants of the embryonic notochord, most often in the skull base, spine, or sacrum. Although it often grows slowly, it can affect nearby nerves and tissues, so early specialist assessment and coordinated treatment planning are important.

Chordoma Cancer Overview

Chordoma cancer is a rare malignant bone tumor that arises from small remnants of the notochord, a structure involved in early spinal development before birth. These remnants can remain in the body and, rarely, develop into a chordoma later in life. Chordomas most often occur along the body’s central axis: at the base of the skull, in the mobile spine, or in the sacrum at the bottom of the spine.

Many chordomas grow slowly, but they can be locally invasive. This means they may extend into nearby bone, muscles, nerves, blood vessels, or organs. Their location can make treatment complex, particularly when a tumor is close to the brainstem, spinal cord, pelvic nerves, or major blood vessels.

Chordoma is different from more common cancers that begin in organs such as the lung, breast, or colon. Care is usually coordinated by a specialist multidisciplinary team, often including orthopedic or neurosurgeons, radiation oncologists, medical oncologists, radiologists, pathologists, rehabilitation professionals, and supportive-care clinicians.

Symptoms and When to Seek Medical Care

Symptoms of chordoma cancer depend mainly on where the tumor is located. Because these tumors may grow gradually, symptoms can initially be vague and may be mistaken for more common spine, sinus, or nerve conditions. Persistent or progressively worsening symptoms deserve medical assessment, especially when they are not improving with usual care.

• Skull-base chordoma may cause double vision, headache, facial numbness, trouble swallowing, hearing changes, balance problems, or weakness of facial muscles.
• Spinal chordoma may cause persistent neck or back pain, numbness, tingling, weakness, changes in walking, or pain that travels into an arm or leg.
• Sacral chordoma may cause deep low-back or pelvic pain, bowel or bladder changes, sexual dysfunction, leg symptoms, or a feeling of fullness in the pelvic area.

Medical care should be sought promptly for new weakness, loss of bladder or bowel control, numbness around the groin or buttocks, severe or rapidly worsening pain, difficulty walking, or new problems with vision, swallowing, or speech. These symptoms do not always mean chordoma, but they need timely evaluation to identify the cause and protect nerve function.

Are Chordomas Rare?

Yes. Chordomas are rare tumors, and they represent only a small proportion of primary bone cancers. They can occur at almost any age but are more often diagnosed in adults. Some forms may occur in children and young adults, particularly when there is an underlying genetic predisposition, although this is uncommon.

Most chordomas occur without a known inherited cause. In a small number of families, changes involving the TBXT gene have been associated with a higher likelihood of chordoma. A doctor may recommend genetic counseling when there is a family history of chordoma, multiple affected relatives, or an unusually young age at diagnosis.

Because the condition is uncommon, review by clinicians and pathologists with chordoma experience can be valuable. Accurate classification is important, as chordoma can resemble other bone and soft-tissue tumors on scans and under the microscope, while treatment planning may differ substantially.

How Chordoma Cancer Is Diagnosed

Diagnosis commonly begins with a medical history, physical and neurological examination, and imaging. Magnetic resonance imaging (MRI) is particularly useful for showing the tumor’s relationship to the spinal cord, brainstem, nerves, and soft tissues. Computed tomography (CT) may help define bone involvement and assist with surgical planning. Additional scans may be used to look for spread to other areas of the body when appropriate.

A biopsy is needed to confirm chordoma cancer. The biopsy pathway should be planned by the team that may perform later surgery, because the route used to obtain tissue can affect future treatment options. A pathologist examines the sample and may use specialized testing, including markers such as brachyury, to help distinguish chordoma from other tumors.

Once the diagnosis is confirmed, the team assesses the tumor’s location, size, involvement of nearby structures, and whether it has returned after prior treatment. These details guide decisions about surgery, radiation, systemic treatment, monitoring, and rehabilitation. A second pathology or imaging review at a specialist center may be considered when findings are uncertain or treatment choices are especially complex.

Can Chordoma Be Cured?

Chordoma can sometimes be treated with curative intent, especially when it is localized and can be removed completely or nearly completely with an adequate margin, followed when indicated by high-dose targeted radiation. However, a cure cannot be promised for any individual. Tumor position may limit how much tissue can safely be removed, particularly near vital nerves, the brainstem, spinal cord, or pelvic organs.

Even after successful initial treatment, chordoma can recur locally, sometimes many years later. For this reason, long-term follow-up with regular imaging is a central part of care. If a recurrence occurs, treatment may still be possible and is individualized based on previous surgery or radiation, current tumor location, overall health, and treatment goals.

When cure is unlikely, treatment can still aim to slow tumor growth, preserve function, manage symptoms, and maintain quality of life. Open discussion with the clinical team helps patients understand whether the recommended plan is intended to remove all visible disease, control a remaining tumor, or relieve symptoms.

What Are the New Treatment Options for Chordoma?

The main advances in chordoma treatment have focused on more precise local therapy and better selection of treatments for recurrent or advanced disease. Surgery remains a key approach when a tumor can be safely removed. Modern planning may involve staged procedures, image guidance, reconstruction techniques, and specialist input to balance tumor control with preservation of neurological and physical function.

High-dose radiation delivered with great precision is an important option, particularly after surgery or when complete surgery is not feasible. Proton beam therapy and carbon-ion therapy can reduce radiation exposure to some nearby healthy tissues while delivering a therapeutic dose to the tumor. The best radiation technique depends on the chordoma’s location, prior radiation exposure, availability, and the experience of the treating center.

For chordoma that cannot be treated adequately with surgery or radiation, or that has spread, medical oncology may discuss systemic therapies. Some targeted medicines may be used in selected situations, often guided by tumor features and prior treatment. Immunotherapy and other targeted approaches are being studied in clinical trials, but they are not established as effective for every patient. Supportive care, pain management, physical rehabilitation, and emotional support remain important alongside tumor-directed treatment.

Acıbadem Health Point’s multidisciplinary specialists and JCI-accredited hospitals assess and treat complex tumors for international patients, with treatment plans based on tumor location, prior care, and individual clinical needs.

What Is the Average Life Expectancy for Someone With Chordoma?

There is no single average life expectancy that accurately describes every person with chordoma. Outcomes vary considerably according to the tumor’s site, size, subtype, whether it has spread, whether it can be fully treated locally, and whether it returns after treatment. A person’s age, general health, and response to treatment also matter.

Chordoma may follow a long course because it can grow slowly, and many people live for years after diagnosis. At the same time, local recurrence and damage caused by a tumor near important structures can affect long-term health. Statistics from groups of patients cannot predict what will happen for one individual, and published results may reflect older treatment techniques rather than current specialist care.

The most useful prognosis discussion is with the treating team after imaging, pathology, and treatment feasibility have been reviewed. Patients may wish to ask about the aim of treatment, the chance of local control, potential effects on function, the follow-up schedule, and what signs should prompt earlier review.

Follow-Up, Recovery and Ongoing Support

Follow-up after chordoma treatment is long term. MRI or other imaging is usually performed at planned intervals to look for recurrence or progression. The schedule varies by tumor site, treatment received, and individual Cancer Risk Factors: Lifestyle, Genetics, and Age" class="ahp-ilk">risk factors. Keeping follow-up appointments is important even when a person feels well, because recurrence may be detected on imaging before it causes symptoms.

Recovery needs can differ widely. Surgery or radiation near the spine, skull base, or sacrum may affect mobility, balance, swallowing, bowel or bladder function, pain levels, or fatigue. Rehabilitation may include physiotherapy, occupational therapy, speech and swallowing therapy, pain management, continence support, and psychological care. These services can help people return to daily activities as safely and comfortably as possible.

There is no proven lifestyle measure that prevents chordoma or guarantees that it will not recur. General measures such as avoiding tobacco, maintaining nutrition and activity within medical advice, sleeping well, and seeking support for anxiety or low mood can support overall health during and after treatment. New or changing neurological symptoms, increasing pain, or bowel and bladder changes should be reported promptly.

Frequently asked questions